Report: Malaysia tested 'controversial' drug without harm to Covid-19 patients


  • Nation
  • Wednesday, 17 Jun 2020

KUALA LUMPUR: Amid a controversy relating to the use of hydroxychloroquine on Covid-19 patients, Malaysia found a way to test the anti-malaria drug on patients of the respiratory disease without harming them, says a report.

Based on interviews recorded for the report "The Malaysian Response to Covid-19: Building Preparedness for ‘Surge Capacity’, Testing Efficiency, and Containment", Malaysia relied on Chinese expertise which found that lower doses of the drug were effective, while monitoring closely for heart issues and acknowledging the need for high quality evidence.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Nation

Upko ready to face early Sabah polls, says Youth chief
Malaysia believes Spanish court will deliver justice in ex-arbitrator Stampa's trial
Suspected drug trafficker who gave cops the slip two weeks ago nabbed in Arau
Badly decomposed body found at Pulau Pangkor
Hacking issue: Human Resource Ministry taking appropriate action to avoid recurrence, says Sivakumar
Special forum to discuss legal means to end genocide in Palestine, Nurul Izzah to moderate
PBAPP directed to plan for earlier restoration of water supply, says CM
'No one will ever know the strength of my love for you', says Zayn Rayyan's mother
King expresses regret, disappointment over US veto of UNSC draft resolution on Gaza ceasefire
Election Court dismisses petition to annul Gombak Setia rep Hilman's victory

Others Also Read